Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

High dose Ifosfamide and Mitoxantrone (HDIM) as cytoreductive and mobilisation protocol for relapsed and refractory lymphoma, phase I-II study (CROSBI ID 494372)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Nemet, Damir ; Sertić, Dubravka ; Radman, Ivo ; Aurer, Igor ; Zupančić-Šalek, Silva ; Golubić-Ćepulić, Branislava ; Bojanić, Ines ; Batinić, Drago ; Serventi-Seiwerth, Ranka ; Bogdanić, Vinko et al. High dose Ifosfamide and Mitoxantrone (HDIM) as cytoreductive and mobilisation protocol for relapsed and refractory lymphoma, phase I-II study // The Hematology Journal, 3(Suppl 1). 2002. str. 40-x

Podaci o odgovornosti

Nemet, Damir ; Sertić, Dubravka ; Radman, Ivo ; Aurer, Igor ; Zupančić-Šalek, Silva ; Golubić-Ćepulić, Branislava ; Bojanić, Ines ; Batinić, Drago ; Serventi-Seiwerth, Ranka ; Bogdanić, Vinko ; Labar, Boris

engleski

High dose Ifosfamide and Mitoxantrone (HDIM) as cytoreductive and mobilisation protocol for relapsed and refractory lymphoma, phase I-II study

High dose Ifosfamide and Mitoxantrone (HDIM) as cytoreductive and mobilisation protocol for relapsed and refractory lymphoma, phase I-II study

Mitoxantrone; Ifosfamide; relapsed and refractory lymphoma

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

40-x.

2002.

objavljeno

Podaci o matičnoj publikaciji

The Hematology Journal, 3(Suppl 1)

Podaci o skupu

7th Meeting of the European Hematology Association

poster

06.06.2002-09.06.2002

Firenca, Italija

Povezanost rada

Kliničke medicinske znanosti